Nobel Laureate Eric Kandel Draws Large Crowd for Talk
Nobel Laureate Eric Kandel, MD, presented the Lurie Family Endowed Psychiatry and Behavioral Neuroscience Lecture and was honored by the UC Department of Psychiatry and Behavioral Neuroscience Wednesday, Oct. 3, in the Medical Sciences Buildings Kresge Auditorium. His topic was, "Mice, Men and Mental Illness.
Kandel is University Professor at Columbia University, Fred Kavli Professor and Director, Kavli Institute for Brain Sciences, and a senior investigator at the Howard Hughes Medical Institute. For his work on learning and memory using the nervous system of a sea slug as an experimental model, Kandel was awarded a share of the 2000 Nobel Prize in Physiology or Medicine.
A large crowd filled the auditorium, including the balcony, to hear Kandel discuss research in his lab focusing on mouse models of schizophrenia. He blended scientific wisdom with wit, drawing laughter early in his talk by saying, "The best way to do good science is to get colleagues who are better than yourself.
Kandel told the audience that mouse models are useful in studying psychological disorders by focusing on specific genes, adding, "New treatments may have to be developed one symptom at a time.
Before his talk, Kandel received a plaque commemorating his visit from Stephen Strakowski (at right in photo), MD, the Dr. Stanley and Mickey Kaplan Professor and Chair of Psychiatry and Behavioral Neuroscience, and Henry Nasrallah (at left), MD, vice chair for education and training. The Lurie Family Endowed Psychiatry and Behavioral Neuroscience Lecture is part of the department of psychiatry and behavioral neurosciences continuing education program.
Tags
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.